New treatments for hypothyroidism
New Approaches for the treatment of Hypothyroidism
['FUNDING_R01'] · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · NIH-10944695
This study is looking at new ways to treat hypothyroidism by testing a combination of two thyroid hormones to see how they work together, and it's for people who want better options for managing their condition.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CONNECTICUT SCH OF MED/DNT (nih funded) |
| Locations | 1 site (FARMINGTON, UNITED STATES) |
| Trial ID | NIH-10944695 on ClinicalTrials.gov |
What this research studies
This research investigates innovative treatment options for hypothyroidism, a condition that can lead to cardiovascular issues and reduced quality of life. The study focuses on the combination of synthetic thyroid hormones, levothyroxine (LT4) and liothyronine (LT3), to determine the most effective dosing and administration methods. By analyzing how these hormones interact in the body, the research aims to find a safe and effective regimen that can be used in larger clinical trials. Patients may be involved in trials assessing the efficacy and safety of these combination therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with hypothyroidism who are currently experiencing inadequate management of their condition.
Not a fit: Patients who do not have hypothyroidism or those whose condition is well-managed with existing treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options for hypothyroidism, enhancing patient outcomes and quality of life.
How similar studies have performed: Previous studies have shown mixed results with combination therapies for hypothyroidism, indicating a need for further investigation into optimal treatment regimens.
Where this research is happening
FARMINGTON, UNITED STATES
- UNIVERSITY OF CONNECTICUT SCH OF MED/DNT — FARMINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CELI, FRANCESCO S — UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
- Study coordinator: CELI, FRANCESCO S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.